Kalvoncu, U. Et Al. 2018. PSAID-12 CAN BE USED TO DETERMINE THE ANTI-TNF TREATMENT DECISION IN THE PSORIATIC ARTHRITIS REGISTRY. Congress of the European-League-Against-Rheumatism (EULAR) , (Amsterdam, Netherlands), 1601-1602.

Kalvoncu, U., Kiraz, S., Bilgen, S. A., Karadag, O., Akdogan, A., Kilic, L., ... Erden, A.(2018). PSAID-12 CAN BE USED TO DETERMINE THE ANTI-TNF TREATMENT DECISION IN THE PSORIATIC ARTHRITIS REGISTRY . Congress of the European-League-Against-Rheumatism (EULAR) (pp.1601-1602). Amsterdam, Netherlands

Kalvoncu, U. Et Al. "PSAID-12 CAN BE USED TO DETERMINE THE ANTI-TNF TREATMENT DECISION IN THE PSORIATIC ARTHRITIS REGISTRY," Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 2018

Kalvoncu, U. Et Al. "PSAID-12 CAN BE USED TO DETERMINE THE ANTI-TNF TREATMENT DECISION IN THE PSORIATIC ARTHRITIS REGISTRY." Congress of the European-League-Against-Rheumatism (EULAR) , Amsterdam, Netherlands, pp.1601-1602, 2018

Kalvoncu, U. Et Al. (2018) . "PSAID-12 CAN BE USED TO DETERMINE THE ANTI-TNF TREATMENT DECISION IN THE PSORIATIC ARTHRITIS REGISTRY." Congress of the European-League-Against-Rheumatism (EULAR) , Amsterdam, Netherlands, pp.1601-1602.

@conferencepaper{conferencepaper, author={U. Kalvoncu Et Al. }, title={PSAID-12 CAN BE USED TO DETERMINE THE ANTI-TNF TREATMENT DECISION IN THE PSORIATIC ARTHRITIS REGISTRY}, congress name={Congress of the European-League-Against-Rheumatism (EULAR)}, city={Amsterdam}, country={Netherlands}, year={2018}, pages={1601-1602} }